The prominent factors identified in the simulated models include age, Ki-67, tumor origin (especially pancreatic and lung tumors), serum chromogranin A, tumor markers (CA19-9, CEA, AFP), immunohistochemical marker CK7, completed or ongoing oncological treatment, number of metastatic lymph nodes, and tumor size. The gene discussed is CEACAM5; the disease is neoplasm.